TRVI logo

Trevi Therapeutics, Inc. (TRVI) Cash from financing

annual CFF:

$61.48M+$69.39M(+877.29%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TRVI annual cash flow from financing activities is $61.48 million, with the most recent change of +$69.39 million (+877.29%) on December 31, 2024.
  • During the last 3 years, TRVI annual CFF has risen by +$40.71 million (+195.95%).
  • TRVI annual CFF is now -44.76% below its all-time high of $111.31 million, reached on December 31, 2022.

Performance

TRVI Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

quarterly CFF:

$110.39M+$101.69M(+1168.18%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRVI quarterly cash flow from financing activities is $110.39 million, with the most recent change of +$101.69 million (+1168.18%) on June 30, 2025.
  • Over the past year, TRVI quarterly CFF has increased by +$105.33 million (+2078.71%).
  • TRVI quarterly CFF is now at all-time high.

Performance

TRVI quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

TTM CFF:

$175.54M+$105.33M(+150.00%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRVI TTM cash flow from financing activities is $175.54 million, with the most recent change of +$105.33 million (+150.00%) on June 30, 2025.
  • Over the past year, TRVI TTM CFF has increased by +$169.05 million (+2602.77%).
  • TRVI TTM CFF is now at all-time high.

Performance

TRVI TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TRVI Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+877.3%+2078.7%+2602.8%
3 y3 years+195.9%+97.2%+153.6%
5 y5 years-16.0%+10000.0%+10000.0%

TRVI Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-44.8%+877.3%at high+1540.6%at high+2319.3%
5 y5-year-44.8%+877.3%at high+1540.6%at high+2319.3%
alltimeall time-44.8%+877.3%at high+1540.6%at high+2319.3%

TRVI Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
$110.39M(+1168.2%)
$175.54M(+150.0%)
Mar 2025
-
$8.71M(-83.1%)
$70.22M(+14.2%)
Dec 2024
$61.48M(-877.3%)
$51.47M(+933.9%)
$61.48M(+517.1%)
Sep 2024
-
$4.98M(-1.8%)
$9.96M(+53.4%)
Jun 2024
-
$5.07M(<-9900.0%)
$6.50M(-204.2%)
Mar 2024
-
-$28.00K(-48.1%)
-$6.24M(-21.2%)
Dec 2023
-$7.91M(-107.1%)
-$54.00K(-103.6%)
-$7.91M(+9.8%)
Sep 2023
-
$1.51M(-119.7%)
-$7.20M(-115.5%)
Jun 2023
-
-$7.66M(+350.0%)
$46.59M(-57.7%)
Mar 2023
-
-$1.70M(-361.2%)
$110.23M(-1.0%)
Dec 2022
$111.31M(+435.8%)
$652.00K(-98.8%)
$111.31M(-10.5%)
Sep 2022
-
$55.30M(-1.2%)
$124.40M(+79.7%)
Jun 2022
-
$55.98M(-9056.5%)
$69.23M(+332.6%)
Mar 2022
-
-$625.00K(-104.5%)
$16.00M(-23.0%)
Dec 2021
$20.77M
$13.74M(>+9900.0%)
$20.77M(+170.8%)
DateAnnualQuarterlyTTM
Sep 2021
-
$134.00K(-95.1%)
$7.67M(-67.5%)
Jun 2021
-
$2.75M(-33.6%)
$23.63M(+13.3%)
Mar 2021
-
$4.15M(+551.0%)
$20.87M(+24.8%)
Dec 2020
$16.72M(-77.2%)
$637.00K(-96.0%)
$16.72M(+4.0%)
Sep 2020
-
$16.09M(<-9900.0%)
$16.08M(<-9900.0%)
Jun 2020
-
-$12.00K(<-9900.0%)
-$150.00K(-100.2%)
Mar 2020
-
$0.00(0.0%)
$63.36M(-13.5%)
Dec 2019
$73.21M(+1916.3%)
$0.00(-100.0%)
$73.21M(+2.1%)
Sep 2019
-
-$138.00K(-100.2%)
$71.70M(-0.2%)
Jun 2019
-
$63.50M(+544.8%)
$71.84M(+1319.8%)
Mar 2019
-
$9.85M(-753.1%)
$5.06M(-205.7%)
Dec 2018
$3.63M(-83.3%)
-$1.51M(-54.0%)
-$4.79M(+46.0%)
Jun 2018
-
-$3.28M
-$3.28M
Dec 2017
$21.73M(+152.8%)
-
-
Dec 2016
$8.60M
-
-

FAQ

  • What is Trevi Therapeutics, Inc. annual cash flow from financing activities?
  • What is the all time high annual CFF for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. annual CFF year-on-year change?
  • What is Trevi Therapeutics, Inc. quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. quarterly CFF year-on-year change?
  • What is Trevi Therapeutics, Inc. TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. TTM CFF year-on-year change?

What is Trevi Therapeutics, Inc. annual cash flow from financing activities?

The current annual CFF of TRVI is $61.48M

What is the all time high annual CFF for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high annual cash flow from financing activities is $111.31M

What is Trevi Therapeutics, Inc. annual CFF year-on-year change?

Over the past year, TRVI annual cash flow from financing activities has changed by +$69.39M (+877.29%)

What is Trevi Therapeutics, Inc. quarterly cash flow from financing activities?

The current quarterly CFF of TRVI is $110.39M

What is the all time high quarterly CFF for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $110.39M

What is Trevi Therapeutics, Inc. quarterly CFF year-on-year change?

Over the past year, TRVI quarterly cash flow from financing activities has changed by +$105.33M (+2078.71%)

What is Trevi Therapeutics, Inc. TTM cash flow from financing activities?

The current TTM CFF of TRVI is $175.54M

What is the all time high TTM CFF for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high TTM cash flow from financing activities is $175.54M

What is Trevi Therapeutics, Inc. TTM CFF year-on-year change?

Over the past year, TRVI TTM cash flow from financing activities has changed by +$169.05M (+2602.77%)
On this page